PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Nepafenac - Postoperative pain and inflammation (eye)
PAD Profile : Nepafenac - Postoperative pain and inflammation (eye)
Brand Names Include :
Nevanac
Traffic Light Status
Status 1 of 1.
Guidelines
No guidelines returned.
Other Drugs
Other Indications
No indications returned.
Additional Documents
No additional documents returned.
Committee Recommendations
Date
Committee Name
Narrative
28 November 2013
ASPH DTC
The committee supported the use of nepafenac within its licensed indications. As treatment is short term postoperatively (up to 60 days with a review by the specialist 1 month post operatively) it was agreed that this would be considered as a red drug on the traffic light system.
Associated BNF Codes
11. Eye
11.08.02. Ocular diagnostic & peri-operative prepn & photodynamic tt